MedPath

Speech characteristics in Individuals with Unipolar depression, bipolar depression, and Schizophrenia

Not Applicable
Conditions
Health Condition 1: F317- Bipolar disorder, currently in remissionHealth Condition 2: F334- Major depressive disorder, recurrent, in remissionHealth Condition 3: F20- Schizophrenia
Registration Number
CTRI/2024/03/063632
Lead Sponsor
Cognitive Science Research Initiative
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

Group 1

Individuals having the primary diagnosis of unipolar depression based on standard ICD 10 diagnostic criteria. Individuals having HAM-D (Hamilton Depression Rating Scale) score between 14-28 indicative of moderately and moderately severe degree of depression, having recurrent episodes and the duration of symptoms is more than two weeks

Group 2

Individuals having the primary diagnosis of bipolar depression based on standard ICD 10 diagnostic criteria. Individuals should be in the depressive state for past three months (rated on scales of depression; HAM-D) and mania (Young Mania Rating Scale) for validation of present state. Individuals should have been on stable medication regime since three months

Group 3

Individuals having the primary diagnosis of schizophrenia based on standard ICD 10 diagnostic criteria. Individuals should have been on stable medication regime since three months and having the same diagnosis since two years

Group 4

Individuals with age, gender and education matched and not meeting the diagnostic criteria for unipolar depression or bipolar depression or schizophrenia or any other mental illness

Individuals in all groups should have Kannada as their first language and language of communication

Exclusion Criteria

Groups 1, 2, and 3

Individuals with neurological conditions/history of substance abuse except on nicotine since past 6 months/epilepsy/traumatic brain injury/having uncorrected hearing and vision, uncontrolled medical conditions or co-morbid conditions. Individuals with any other speech-language deficits such as stuttering, aphasia, dysarthria or dementia. Individuals having visual impairment or color blindness and those who are uncooperative, which interferes with language sample collection. Specifically for group 3, individuals having post schizophrenia depression

Group 4

Participants with any history psychiatric illness or first degree relative with history of affective disorders, dementia, cerebrovascular disease. Individuals with history of substance abuse (except nicotine)

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Auditory verbal comprehension, repetition, namingTimepoint: 24 months
Secondary Outcome Measures
NameTimeMethod
Discourse markersTimepoint: 24 months
© Copyright 2025. All Rights Reserved by MedPath